Mumbai, April 1st, 2020 - Qure.ai (www.qure.ai), a global leader in artificial intelligence (AI) solutions for radiology today announced that they will be working with the Italian San Raffaele university hospital to monitor disease progression in COVID-19 patients. Qure.ai’s automated chest X-ray solution, qXR interprets a COVID-19 patient’s lung scans in seconds and quantifies how much of their lungs have been affected by the viral infection. This enables the time and resource-strapped clinicians to monitor disease progression more accurately and efficiently.
COVID-19 patients need frequent monitoring of their lung infection using chest X-rays. However, quantifying the extent of the infection is a time-consuming step for already overloaded radiologists and the results are often inconsistent. This is where Qure.ai’s qXR can help. qXR can detect findings like ground-glass opacities and consolidation abnormalities that are indicative of COVID-19. The AI-powered solution also helps detect tuberculosis, chronic obstructive pulmonary diseases, lung malignancies and medical emergencies like lung collapses and cardiac disorders. It can also localize lesions and quantify the volume of an infection.
"By using our technology, doctors can objectively monitor disease progression in a COVID-19 patient and their response to new therapeutic approaches,” said Prashant Warier, CEO and Co-Founder of Qure.ai.
Italy, one of the most affected countries by the COVID-19 pandemic is grappling to contain the spread of the virus and treat its patients. Its healthcare infrastructure has been under intense pressure to control the viral transmission, diagnose and treat patients fast, while also dealing with staff shortages, among other things.
“Our expertise with tackling Tuberculosis has served us well in developing AI solutions to fight the COVID-19 pandemic. The algorithm we’ve created will help to reduce the workload of hospital staff, as well as to devise the best treatment options for patients, at different stages of COVID-19. We believe the technology will also help to aid in the discovery of new drugs and therapeutic approaches,” Warier concluded.
For more information: http://qure.ai/
About Qure.ai
Headquartered in Mumbai, India, with U.S. operations based in New York, Qure.ai is a breakthrough Artificial Intelligence (AI) solution that is disrupting the radiology ‘status quo’ by enhancing imaging accuracy and improving health outcomes with the assistance of machine-supported tools. Qure.ai taps deep learning technology to provide automated interpretation of radiology exams like X-rays, CTs and MRI scans for time and resource-strapped medical imaging professionals—enabling faster diagnosis and speed to treatment. Qure.ai is helping to make healthcare more accessible and affordable to patients worldwide.
Back to HCB News
